Program for October 24 (Fri), Day 2/JDDW 2014 - KOBE
Oral presentation schedule for October 24 (Fri), Day 2
    Kobe International Exhibition Hall No.2 Building Portopia Hotel Kobe International Conference Center Kobe International Exhibition Hall No.1 Building Kobe International Exhibition Hall No.3 Building Portopia Hotel  
  Hall (North) Hall (South) Conference Room 3A Portopia Hall Ohwada A Ohwada B Ohwada C Kairaku 1+2 Kairaku 3 Waraku Topaz Main Hall International Conference Room Digital Poster Session & Commercial Exhibition Digital Poster Session & Commercial Exhibition Emerald  
  Room 1 Room 2 Room 3 Room 4 Room 5 Room 6 Room 7 Room 8 Room 9 Room 10 Room 11 Room 12 Room 13 Room 14 Room 15 Room 16  
8:00 8:00
45 No planned seminars No planned seminars No planned seminars No planned seminars

Breakfast
Seminar5

Century Medical Inc.
Impressive Case –The reason to be a Hepato-Biliary-Pancreas endoscopic surgeon–

Breakfast
Seminar6

Otsuka Pharmaceutical Co., Ltd.
New strategies for NSAIDs-induced gastrointestinal damage

Breakfast
Seminar7

ABBOTT JAPAN Co., LTD.
The utility of serum pepsinogen levels for the diagnosis of Helicobacter pylori associated gastritis

Breakfast
Seminar8

ASKA Pharmaceutical Co., Ltd./ NIHON PHARMACEUTICAL CO., LTD
Key points and techniques for comfortable endoscopy

Breakfast
Seminar9

DAIICHI SANKYO CO., LTD./ AstraZeneka K.K.
A correct comprehension of Gastric cancer risk classification (ABC classification) –To prevent from overlooking high risk group A–

Breakfast
Seminar10

Takeda Pharmaceutical Company Limited
The Essence of Endoscopic Diagnosis Not to Overlook Infectious Gastritis of Helicobacter pylori

Breakfast
Seminar11

Eisai Co., Ltd.
Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma in Japan

Breakfast
Seminar12

Takeda Pharmaceutical Company Limited
Possible interaction between life style-related diseases and gastrointestinal-liver diseases: especially focused on NASH

Breakfast
Seminar13

MIYARISAN PHARMACEUTICAL CO., LTD.
The New Era of Probiotics Research in the Field of Inflammatory Bowel Disease
      45
9:00                           9:00
30

S8 (JSGE/JGES)
A new era of H. pylori research - From pathophysiology to eradication -

Chair: T. Sugiyama
K. Murakami

S9 (JGES)
Up-to-date evidence in image enhance endoscopy and microscopic
endoscopy for the upper GI tract

Chair: M. Kaise
H. Inoue

S11 (JGES/JSGE/
JSH/JSGS)
Update on treatment of gastric varices and problems to be solved.

Chair: K. Obara
S. Kokubu

PD8 (JSH/JSGE)
The cutting edge of therapeutic strategies for liver diseases based on imaging modalities

Chair: F. Moriyasu
Y. Imai

IS-S4 (JSGE)
Therapeutic strategy of IBS based on pathophysiology

Chair: Y. Fujiyama
S. Fukudo

W5 (JGES)
ESD update-Innovation in techniques and devices-Lower GI

Chair: H. Yamamoto
T. Toyonaga

PD10 (JSGCS/
JGES)
Status quo and problems of organized screening by endoscopy

Chair: M. Kobayashi
M. Yasuda

PD11 (JSH/JSGE/
JGES/JSGS)
New therapeutic strategies for complications in patients with liver cirrhosis

Chair: Y. Murawaki
H. Moriwaki
Live broadcast Room 1 Live broadcast Room 2 Live broadcast Room 3

W8 (JSH/JSGE)
Future perspective of hepatology in terms of transition of life style and liver pathogenesis

Chair: E. Hashimoto
Y. Takei

W9 (JSGE/JGES)
Intractable and rare disorders of the gastrointestinal tract

Chair: T. Matsumoto
T. Kanai
 Commercial Exhibition   Commercial Exhibition Gastrointestinal and Pancreaticobiliary Endoscopy Live Seminar (JGES) 30
10:00
Digital Poster Session
(JSGE)
9:30-11:30
 
Digital Poster Session
(JSGCS)
9:30-11:30
  10:00
11:00     11:00
10

Invited Lecture (Keynote Lecture) (JSGE)
Therapeutic strategy for IBS and FD based on pathophysiology

N. Talley
Chair: S. Fukudo
    10
20

Special Lecture (JSGCS)
Gastrointestinal cancer screening - Trends in the world and a prospect in Japan

H. Saito
Chair: K. Inoue
20
30

Invited Lecture (JGES)
GI endoscopy abroad: Experience from a 45 year career in the USA

C. Sugawa
Chair: R. Fujita
30
12:00     12:00
30                                 30
13:00

Luncheon
Seminar39

DAIICHI SANKYO CO., LTD./ AstraZeneka K.K.
Re-evaluation of the management of drug-induced GI injury

Luncheon
Seminar40

Nippon Kayaku Co., Ltd.
New Strategy in Transcatheter Arterial Chemoembolization

Luncheon
Seminar41

Abbott Japan Co., Ltd.
Japanese Chronic Constipation Treatment’s “Galapagos Syndrome”
No planned seminars

Luncheon
Seminar42

AbbVie G.K./ Eisai Co., Ltd.
New treatment strategies in Ulcerative Colitis

Luncheon
Seminar43

Olympus Medical Systems Corp.
New trend of ESD –Pursue the safer and more reliable treatment–

Luncheon
Seminar44

Meiji Co., Ltd.
Management of Helicobacter pylori infection in Japan

Luncheon
Seminar45

CHUGAI PHARMACEUTICAL CO., LTD.
The 7th CHUGAI Award Ceremony
Antiviral treatment for chronic hepatitis C –Current status and future perspective–

Luncheon
Seminar46

AJINOMOTO PHARMA CEUTICALS CO., LTD.
What is the best treatment strategy for Crohn’s disease in Europe and Japan?

Luncheon
Seminar47

Otsuka Pharmaceutical Co., Ltd.
Ceremony & Luncheon Seminar
Significance and Importance of then Nutrition Treatment in Liver Cirrhosis

Luncheon
Seminar48

Nippon Boehringer Ingelheim Co., Ltd / Eli Lilly Japan K.K.
How should we treat hyperglycemia to reduce the risk of diabetic complications

Luncheon
Seminar49

Takeda Pharmaceutical Company Limited
GERD and obesity
Representative Conference (Japanese Society of Gastrointestinal Cancer Screening)
12:30-13:30
13:00
30       30
40   40
14:00                         14:00
30

PD7 (JSH/JSGE/
JSGS)
Multidisciplinary therapy of advanced heatocellular carcinoma from the viewpoint of prognosis and QOL

Chair: Y. Ku
M. Kudo

S10 (JGES)
Up-to-date evidence in image enhance endoscopy and microscopic endoscopy for the lower GI tract

Chair: H. Ogata
S. Tanaka

W4 (JSGE/JGES)
Revisited gastro-duodenal defense mechanism

Chair: K. Higuchi
Y. Naito

Special Lecture (JGES)
Surgery or endoscopy? Endoscopic science from a view-point of a surgeon

M. Kaminishi
Chair: K. Kumagai

Invited Lecture (Keynote Lecture) (JSGE)
The microbiota in IBD

F. Shanahan
Chair: H. Nakase

Integrated Program1 (JDDW(JSH)/JSH/JSGS)
Treatment options and their selection for patients with metastatic liver tumor

Chair: S. Shiina
H. Baba

Lecture by Congress President (JSH)
Endotoxin research and hepatology: Evolving science over the past half century

H. Fukui
Chair: M. Imawari

W7 (JSH/JSGE/
JSGS)
Optimization of personalized therapy in elderly patients with liver diseases

Chair: Y. Osaki
Y. Asahina

Women's Committee of Japanese Gastroenterology Study Group (JDDW)
Ladies, be tough and gentle!

Chair: K. Hino
F. Kurokawa
Live broadcast Room 1 Live broadcast Room 2

S12 (JSGE/JGES/
JSH)
Lipid and bile acids metabolism in lifestyle related diseases

Chair: S. Tazuma
Y. Matsuzaki

Report (JSGCS)
Annual report of gastrointestinal cancer screening in Japan, 2012

S. Kitagawa
Chair: O. Hosokawa
Digital Poster Session
(JGES)
14:00-16:30
Digital Poster Session
(JSH)
14:00-16:30
Digital Poster Session
(JSGCS)
14:00-16:30
International Poster Session
14:00-16:30
Gastrointestinal and Pancreaticobiliary Endoscopy Live Seminar (JGES) 30
40

PD9 (JGES/JSGE/
JSGCS)
H. pylori eradication therapy: The search for strategies to reduce gastric cancer mortality

Chair: M. Ichinose
N. Uemura

W10 (JSGCS/JSGE/
JSH)
Subjects to spread the guideline for abdominal ultrasound mass screening

Chair: S. Ikeda
T. Hirai
40
15:00

IS-W1 (JSGE/
JGES/JSGS)
Host-microbial interaction in IBD

Chair: A. Andoh
H. Nakase
15:00
16:00

W6 (JSH/JSGE/
JSGS)
Perspectives of pathogenesis and treatment of liver diseases from the aspects of gut-liver axis

Chair: S. Sakisaka
M. Yoneda
16:00
30 30
17:00     17:00
10                                 10
30 Japan Gastroenterological Endoscopy Society Awards Ceremony 30
18:00 Incorporated Association Council and Academic Council (Japan Gastroenterological Endoscopy Society)
17:30-18:45
No planned seminars

Satellite
Symposium81

ASAHI KASEI MEDICAL CO., LTD.
Positioning of LCAP as a therapy of ulcerative colitis: a mechanism-based approach
No planned seminars

Satellite
Symposium82

FUJIFILM Medical Co., Ltd.
Future Prospects for BLI (Blue LASER Imaging) Diagnosis
Clinical Usefulness in Upper Gastrointestinal Endoscopy

Satellite
Symposium83

Janssen Pharmaceutical K.K.
Setting up the JDDW Banquet Room

Satellite
Symposium84

FUJIFILM Medical Co., Ltd.
Astellas Pharma Inc.
Exploration of optimal tacrolimus therapy for refractory ulcerative colitis

Satellite
Symposium85

Bristol-Myers Squibb
New evolution in Chronic hepatitis B treatment
–Strategy based on NAs and IFN therapy–

Satellite
Symposium86

TOSHIBA MEDICAL SYSTEMS CORPORATION

Satellite
Symposium87

Hospira Japan Co., Ltd./ Maruishi Pharmaceutical Co. Ltd.
A novel drug in the sedation of endoscopic therapy- Precedex

Satellite
Symposium88

Otsuka Pharmaceutical Co., Ltd.
How to make use of Tolvaptan in hepatic edema?

Satellite
Symposium89

Mitsubishi Tanabe Pharma Corporation
Therapeutic strategy to Improve refractory HCV Patient
18:00
30   30
45         45
19:00   19:00
30       Social Gathering (after the Satellite Seminar)                 30
20:00         20:00
                                 

Copyright © JDDW 2014. All Rights Reserved.